Compare Abeona Therapeutics Inc (ABEO) vs Flagstar Bank NA (FLG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Flagstar Bank NA — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Flagstar Bank NA trades at $14.23 (market cap $5.89B). The key difference: Flagstar Bank NA is far larger — about 14× Abeona Therapeutics Inc's market cap, and Flagstar Bank NA pays a 0.28% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | FLG | |
|---|---|---|
Market Cap | $421.19M | $5.89B |
Sector | Health | Financials |
52-Week High | $7.45 | $15.36 |
52-Week Low | $4.17 | $10.72 |
Enterprise Value | $276.10M | — |
Dividend Yield | — | 0.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →
